| mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |